Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia- and flagella-associated protein 61 (CFAP61) is an evolutionarily conserved, testis-expressed structural protein integral to the assembly and stability of the axonemal radial spoke and calmodulin- and spoke-associated complex (CSC) in sperm flagella[1][2]. It is required for normal sperm flagellum morphology and motility but appears non-essential in respiratory cilia, distinguishing it from other ciliary proteins[1][2]. Biallelic variants in CFAP61 cause multiple morphological abnormalities of the flagella (MMAF), leading to severe male infertility due to impaired sperm motility and axoneme defects[1][2]. CFAP61 interacts with other structural components of the axoneme and CSC, regulating the assembly of radial spoke clusters and associated protein networks; however, it is not a classic receptor, enzyme, or pharmacological target[1][2]. There are currently no drugs targeting CFAP61, though its genetic defects serve as biomarkers for MMAF diagnosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia- and flagella-associated protein 61 (CFAP61).